Aug 08, 2019 / 12:30PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to the Autolus Therapeutics Second Quarter 2019 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.
And now I would like to turn the conference over to Silvia Taylor, Vice President, Corporate Affairs and Communication. Ma'am, you may begin.
Silvia Taylor - Autolus Therapeutics plc - VP of Corporate Affairs & Communications
Thank you, Lance. Good morning or good afternoon, everyone, and thank you for taking part in today's call. With me today are Dr. Christian Itin, Chairman and Chief Executive Officer; and Andrew Oakley, Chief Financial Officer of Autolus.
Before we begin, I would like to remind you that during this call, we will be making forward-looking statements. All statements other than statements of historical facts contained in this presentation are forward-looking statements. Our actual results, performance or achievements may be materially different from those expressed or implied by the forward-looking statements. For a
Q2 2019 Autolus Therapeutics PLC Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot